Research library
Sources, with the status on the record.
Each row is a paper or a ClinicalTrials.gov entry checked on 21 November 2026. Titles are the authors’ or the registry’s words. Nalen Lab does not restate them as claims about these products. A registration is not a result.
Records checked 2026-11-21. Open registry rows in this view: 0. Selank has published papers and no verified intervention trial.
Loading filters…
Ipamorelin
1998
Publication
Ipamorelin, the first selective growth hormone secretagogue.
Raun K et al. · European Journal of Endocrinology
PublishedSame compound as the catalogue listing
Pharmacology paper in vitro and in animals. DOI 10.1530/eje.0.1390552.
View in the catalogueIpamorelin
1999
Publication
Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.
Gobburu JV et al. · Pharmaceutical Research
PublishedSame compound as the catalogue listing
View in the catalogueIpamorelin
1999
Publication
Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.
Johansen PB et al. · Growth Hormone & IGF Research
PublishedSame compound as the catalogue listing
Rat study. The title is the authors' wording.
View in the catalogueIpamorelin
2011
Registry
Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function
Phase 2 · ClinicalTrials.gov · NCT01280344 · Helsinn Therapeutics (U.S.), Inc
CompletedSame compound as the catalogue listing
Completed. No recruiting ipamorelin trial was verified on 21 November 2026.
View in the catalogueIpamorelin
2008
Registry
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
Phase 2 · ClinicalTrials.gov · NCT00672074 · Helsinn Therapeutics (U.S.), Inc
CompletedSame compound as the catalogue listing
View in the catalogue